Latest Growth Initiatives News

De.mem Limited has acquired Core Chemicals Ltd for approximately $3 million, significantly expanding its footprint in the Australian gold mining sector and enhancing its pro-forma EBITDA to $1.6 million.

Coventry Group reports a 4.5% increase in Q1 FY26 sales alongside a notable EBITDA turnaround, underpinned by a $10 million cost-out program and fresh executive appointments.

AVITA Medical has appointed Board Chairman Cary Vance as Interim CEO following Jim Corbett's departure, while preliminary third-quarter revenue is expected to reach approximately $17 million.

PainChek Limited has appointed Sasha Grant as Head of Growth for its AI-powered Infant App, aiming to scale its presence in a $15 billion global market. Early Australian adoption shows promising conversion rates as the company prepares for international expansion.

Biome Australia Limited has reported a record quarterly revenue of $5.94 million for Q1 FY26, marking a 40% increase year-over-year and its seventh consecutive quarter of positive EBITDA. The company’s strong cash flow and sustained margins underscore its growth momentum.

Solstice Minerals reports its strongest gold drill results yet at Yarri’s Bluetooth and Edjudina Range prospects, while gearing up for a significant copper-gold resource expansion program at Nanadie.

Klevo Rewards has completed a partial entitlement offer, raising $1.77 million with underwriters covering 40% of the targeted $4.12 million capital raise. The company now faces decisions on allocating the remaining shortfall shares.

Connexion Mobility reported a modest 1% revenue increase to $2.9 million in Q1 FY26, while net profit before tax declined 19% due to the absence of prior quarter government incentives. The company is advancing its SaaS platform footprint in US automotive retail and investing strategically in Covertrue Group.

Equity Story Group Ltd (ASX – EQS) has announced a fully underwritten renounceable entitlement offer to raise approximately $3.54 million, aiming to accelerate its entry into the property sector and strengthen working capital.

Cogstate Limited reports a record-breaking quarter with sales contracts soaring 88% year-on-year, driven by expanding markets and new therapeutic areas. The company signals continued investment in growth initiatives, including AI and Asia-Pacific expansion, while projecting a strong first half of FY26.

EVE Health Group Limited has launched a $1.1 million capital raising via a placement to fund the commercial rollout of its two pharmaceutical products, Dyspro and Libbo. The offer includes shares and options, with some subject to shareholder approval.

Pacific Current Group has announced an on-market buy-back of up to 2 million shares, representing nearly 7% of its capital, aiming to enhance earnings per share and capital efficiency.